Publications

ENG

Oral cholera vaccine in cholera prevention and control, Malawi.

Abstract

Problem: With limited global supplies of oral cholera vaccine, countries need to identify priority areas for vaccination while longer-term solutions, such as water and sanitation infrastructure, are being developed.

Authors: M'bangombe M Pezzoli L Reeder B Kabuluzi S Msyamboza K Masuku H Ngwira B Cavailler P Grandesso F Palomares A Beck N Shaffer A MacDonald E Senbete M Lessler J Moore SM Azman AS
Journal Reference: Bulletin of the World Health Organization 2018 Jun 01; 96(6); 428-435. doi: 10.2471/BLT.17.207175. Epub 2018 04 23
ENG

Cholera epidemic in Yemen, 2016-18: an analysis of surveillance data.

Abstract

BACKGROUND: In war-torn Yemen, reports of confirmed cholera started in late September, 2016. The disease continues to plague Yemen today in what has become the largest documented cholera epidemic of modern times.

Authors: Camacho A Bouhenia M Alyusfi R Alkohlani A Naji MAM de Radiguès X Abubakar AM Almoalmi A Seguin C Sagrado MJ Poncin M McRae M Musoke M Rakesh A Porten K Haskew C Atkins KE Eggo RM Azman AS Broekhuijsen M Saatcioglu MA Pezzoli L Quilici ML Al-Mesbahy AR Zagaria N Luquero FJ
Journal Reference: The Lancet. Global health 2018 06 ; 6(6); e680-e690. doi: 10.1016/S2214-109X(18)30230-4. Epub 2018 05 03
ENG

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.

Abstract

BACKGROUND: The fixed dose combination of artemether-lumefantrine (AL) is the most widely used treatment for uncomplicated Plasmodium falciparum malaria.

Authors: Kloprogge F Workman L Borrmann S Tékété M Lefèvre G Hamed K Piola P Ursing J Kofoed PE Mårtensson A Ngasala B Björkman A Ashton M Friberg Hietala S Aweeka F Parikh S Mwai L Davis TME Karunajeewa H Salman S Checchi F Fogg C Newton PN Mayxay M Deloron P Faucher JF Nosten F Ashley EA McGready R van Vugt M Proux S Price RN Karbwang J Ezzet F Bakshi R Stepniewska K White NJ Guerin PJ Barnes KI Tarning J
Journal Reference: PLoS medicine 2018 Jun ; 15(6); e1002579. doi: 10.1371/journal.pmed.1002579. Epub 2018 06 12
ENG

HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015.

Abstract

Background: Kaposi's sarcoma (KS) is a common HIV-associated malignancy associated with disability, pain and poor outcomes.

Authors: Fardhdiani V Molfino L Zamudio AG Manuel R Luciano G Ciglenecki I Rusch B Toutous Trellu L Coldiron ME
Journal Reference: Infectious agents and cancer 2018 ; 13(); 5. doi: 10.1186/s13027-018-0177-6. Epub 2018 01 19
AIDS-related opportunistic infections Acquired immunodeficiency syndrome Doxorubicin Kaposi sarcoma Mozambique
ENG

The new WHO decision-making framework on vaccine use in acute humanitarian emergencies: MSF experience in Minkaman, South Sudan.

Abstract

Introduction: The main causes of death during population movements can be prevented by addressing the population's basic needs.

Authors: Rull M Masson S Peyraud N Simonelli M Ventura A Dorion C Luquero FJ Uzzeni F Cigleneki I
Journal Reference: Conflict and health 2018 ; 12(); 11. doi: 10.1186/s13031-018-0147-z. Epub 2018 03 26
Cholera Crude mortality rate Diarrheal diseases Measles Respiratory infections Safe drinking water South Sudan Under 5 mortality rate Vaccine preventable outbreaks
ENG

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.

Abstract

BACKGROUND: The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB.

Authors: Bastard M Sanchez-Padilla E du Cros P Khamraev AK Parpieva N Tillyashaykov M Hayrapetyan A Kimenye K Khurkhumal S Dlamini T Perez SF Telnov A Hewison C Varaine F Bonnet M
Journal Reference: PloS one 2018 ; 13(3); e0193491. doi: 10.1371/journal.pone.0193491. Epub 2018 03 08
ENG
Authors: Gignoux E Polonsky J Ciglenecki I Bichet M Coldiron M Thuambe Lwiyo E Akonda I Serafini M Porten K
Journal Reference: PloS one 2018 ; 13(3); e0194276. doi: 10.1371/journal.pone.0194276. Epub 2018 03 14
ENG
Authors: Baraka V Mavoko HM Nabasumba C Francis F Lutumba P Alifrangis M Van Geertruyden JP
Journal Reference: PloS one 2018 ; 13(2); e0191922. doi: 10.1371/journal.pone.0191922. Epub 2018 02 01
ENG

Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.

Abstract

BACKGROUND: Cholera remains a persistent health problem in sub-Saharan Africa and worldwide.

Authors: Lessler J Moore SM Luquero FJ McKay HS Grais R Henkens M Mengel M Dunoyer J M'bangombe M Lee EC Djingarey MH Sudre B Bompangue D Fraser RSM Abubakar A Perea W Legros D Azman AS
Journal Reference: Lancet (London, England) 2018 05 12; 391(10133); 1908-1915. doi: 10.1016/S0140-6736(17)33050-7. Epub 2018 03 01
ENG

Near real-time forecasting for cholera decision making in Haiti after Hurricane Matthew.

Abstract

Computational models of cholera transmission can provide objective insights into the course of an ongoing epidemic and aid decision making on allocation of health care resources.

Authors: Pasetto D Finger F Camacho A Grandesso F Cohuet S Lemaitre JC Azman AS Luquero FJ Bertuzzo E Rinaldo A
Journal Reference: PLoS computational biology 2018 05 ; 14(5); e1006127. doi: 10.1371/journal.pcbi.1006127. Epub 2018 05 16